Did you know that your browser is out of date?
For the best experience we recommend upgrading to the latest version of these supported browsers:
I wish to continue viewing on my unsupported browser
Generics: Pay-For-Delay, Patent Settlements, Reverse Payment, Price-Fixing & Market Allocation
Virtual
24 June 2021
Hosted By: Concurrences
How has “pay-for-delay” and reverse payment in pharmaceutical patent settlements been impacted since FTC v. Actavis?
Director Dr. Christine Meyer will speak during a session called “Generics: Pay-For-Delay, Patent Settlements, Reverse Payment, Price-Fixing & Market Allocation” at Concurrences’ 2nd Annual Antitrust in Life Sciences Conference. Dr. Meyer and other panelists from White & Case, Novartis, and the United States FTC will provide an analysis of the current legal and economic landscape of generics in the pharmaceutical industry.
NERA Economic Consulting is proud to sponsor this conference bringing together life sciences leaders in antitrust.
For more information on the conference and to register, please visit the Concurrences website.
To contact us about this event, please click here.